SUSAN CLARK: Open Payments
NPI 1376161950 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,123 in 101 payments from 13 companies in 2025. Trend: 2023 $116 · 2024 $112 · 2025 $2,123
Food & beverage: $2,123
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $333 |
| Janssen Pharmaceuticals, Inc | 15 | $315 |
| E.R. Squibb & Sons, L.L.C. | 9 | $306 |
| Otsuka America Pharmaceutical, Inc. | 11 | $290 |
| Axsome Therapeutics, Inc. | 8 | $238 |
| Alkermes, Inc. | 11 | $197 |
| Neurocrine BioSciences, Inc. | 8 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $122 |
| Lundbeck LLC | 2 | $55 |
| Tris Pharma Inc | 2 | $35 |
Products named: VRAYLAR, COBENFY, Auvelity, INGREZZA, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across FL — which companies pay providers there.
